A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
A Comparitive Study of CA 15.3 Levels in Pre Treated Breast Cancer Patients and Controls
unpublished
Preserved Fulltext
Breast cancer is the leading cause of cancer deaths among women worldwide after carcinoma of cervix uteri. CA 15.3 is the chief tumor marker used in the diagnosis of severity of disease and progression from treatment. Study aimed to evaluate tumor marker CA 15.3 in pre-treated breast cancer patients and to compare it with controls.
fatcat:4bbteyawcnhmliiusrnq75yp5u